Literature DB >> 21480482

Risk factors for aortic valve disease in bicuspid aortic valve: a family-based study.

Troy J Calloway1, Lisa J Martin, Xue Zhang, Animesh Tandon, D Woodrow Benson, Robert B Hinton.   

Abstract

Bicuspid aortic valve (BAV) is the most common cardiovascular malformation and is a risk factor for aortic valve disease (AVD). AVD typically manifests later in life, and the majority of cases have BAV. The purpose of this study was to identify risk factors for AVD in individuals with BAV. Families enriched for BAV were identified in a pediatric population, and echocardiography was performed on all family members. AVD was identified as stenosis and/or insufficiency, and BAV morphology was defined as right-left (RL), right-non (RN) or indeterminate. Heritability (h(2)) of AVD and BAV morphology was estimated using variance components analysis (SOLAR). To assess AVD risk over time, we used Generalized Estimating Equations methodology (SAS) adjusting for age and gender. A total of 1,128 individuals from 226 families were evaluated. BAV was identified in 281 individuals (25%), and AVD was identified in 167 (59%) individuals with BAV. Previously, we identified a high heritability for BAV (h(2)  = 0.89 ± 0.06, P < 0.00001), but the heritability of AVD in the present study (0.07 ± 0.17, P = 0.33) was low. AVD was significantly associated with BAV morphology (P = 0.0027) and age (P = 0.0068). Children with RN BAV and adults with RL BAV were more likely to develop AVD. BAV is determined largely by genetic effects, but the phenotypic variability of AVD is primarily determined by nongenetic factors. BAV morphology may have predictive value for the time course of AVD.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21480482     DOI: 10.1002/ajmg.a.33974

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Factors other than genotype account largely for the phenotypic variation of the pulmonary valve in Syrian hamsters.

Authors:  M Carmen Fernández; Ana C Durán; Borja Fernández; Josep M Arqué; Robert H Anderson; Valentín Sans-Coma
Journal:  J Anat       Date:  2012-05-17       Impact factor: 2.610

Review 2.  Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models.

Authors:  Robert M Weiss; Jordan D Miller; Donald D Heistad
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

Review 3.  A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium).

Authors:  Siddharth K Prakash; Yohan Bossé; Jochen D Muehlschlegel; Hector I Michelena; Giuseppe Limongelli; Alessandro Della Corte; Francesca R Pluchinotta; Maria Giovanna Russo; Artur Evangelista; D Woodrow Benson; Simon C Body; Dianna M Milewicz
Journal:  J Am Coll Cardiol       Date:  2014-08-26       Impact factor: 24.094

4.  Abnormal Longitudinal Growth of the Aorta in Children with Familial Bicuspid Aortic Valve.

Authors:  Holly Nadorlik; Jessica L Bowman; Sara Fitzgerald-Butt; May Ling Mah; Kim L McBride; John P Kovalchin; Vidu Garg
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

5.  Genetically alike Syrian hamsters display both bifoliate and trifoliate aortic valves.

Authors:  Valentín Sans-Coma; M Carmen Fernández; Borja Fernández; Ana C Durán; Robert H Anderson; Josep M Arqué
Journal:  J Anat       Date:  2011-10-30       Impact factor: 2.610

Review 6.  Vascular Genetics: Presentations, Testing, and Prognostics.

Authors:  Aaron W Aday; Sarah E Kreykes; Christina L Fanola
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-11-13

Review 7.  Molecular and cellular aspects of calcific aortic valve disease.

Authors:  Dwight A Towler
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

Review 8.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

9.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

Review 10.  Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

Authors:  Robert B Hinton
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.